Quantification of rare NPM1 mutation subtypes by digital PCR

被引：43

作者：

Bacher, Ulrike ^{[1
]}

Dicker, Frank ^{[1
]}

Haferlach, Claudia ^{[1
]}

Alpermann, Tamara ^{[1
]}

Rose, Dominic ^{[1
]}

Kern, Wolfgang ^{[1
]}

Haferlach, Torsten ^{[1
]}

Schnittger, Susne ^{[1
]}

机构：

[1] MLL Munich Leukaemia Lab, Munich, Germany

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2014年 / 167卷 / 05期

关键词：

digital PCR; real-time PCR; rare NPM1 mutation subtypes; minimal residual disease (MRD); MINIMAL RESIDUAL DISEASE; ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; NORMAL KARYOTYPE; GENE-MUTATIONS; NUCLEOPHOSMIN; PROGNOSIS;

D O I：

10.1111/bjh.13038

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：710 / 714

页数：6

共 10 条

[1] Evaluation Of Different NPM1 Mutations In AML Patients According To Clinical, Cytogenetic and Molecular Features and Impact On Outcome [J].

Alpermann, Tamara ;

Haferlach, Claudia ;

Dicker, Frank ;

Eder, Christiane ;

Kohlmann, Alexander ;

Kern, Wolfgang ;

Haferlach, Torsten ;

Schnittger, Susanne .

BLOOD, 2013, 122 (21)

[2] Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. [J].

Falini, B ;

Mecucci, C ;

Tiacci, E ;

Alcalay, M ;

Rosati, R ;

Pasqualucci, L ;

La Starza, R ;

Diverio, D ;

Colombo, E ;

Santucci, A ;

Bigerna, B ;

Pacini, R ;

Pucciarini, A ;

Liso, A ;

Vignetti, M ;

Fazi, P ;

Meani, N ;

Pettirossi, V ;

Saglio, G ;

Mandelli, F ;

Lo-Coco, F ;

Pelicci, P ;

Martelli, MF .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :254-266

[3] Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations [J].

Gorello, P. ;

Cazzaniga, G. ;

Alberti, F. ;

Dell'Oro, M. G. ;

Gottardi, E. ;

Specchia, G. ;

Roti, G. ;

Rosati, R. ;

Martelli, M. F. ;

Diverio, D. ;

Lo Coco, F. ;

Biondi, A. ;

Saglio, G. ;

Mecucci, C. ;

Falini, B. .

LEUKEMIA, 2006, 20 (06) :1103-1108

[4] Monitoring of Minimal Residual Disease in NPM1-Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group [J].

Kroenke, Jan ;

Schlenk, Richard F. ;

Jensen, Kai-Ole ;

Tschuertz, Florian ;

Corbacioglu, Andrea ;

Gaidzik, Verena I. ;

Paschka, Peter ;

Onken, Shiva ;

Eiwen, Karina ;

Habdank, Marianne ;

Spaeth, Daniela ;

Luebbert, Michael ;

Wattad, Mohammed ;

Kindler, Thomas ;

Salih, Helmut R. ;

Held, Gerhard ;

Nachbaur, David ;

von Lilienfeld-Toal, Marie ;

Germing, Ulrich ;

Haase, Detlef ;

Mergenthaler, Hans-Guenther ;

Krauter, Juergen ;

Ganser, Arnold ;

Goehring, Gudrun ;

Schlegelberger, Brigitte ;

Doehner, Hartmut ;

Doehner, Konstanze .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (19) :2709-2716

[5] Absolute quantitative detection of ABL tyrosine kinase domain point mutations in chronic myeloid leukemia using a novel nanofluidic platform and mutation-specific PCR [J].

Oehler, V. G. ;

Qin, J. ;

Ramakrishnan, R. ;

Facer, G. ;

Ananthnarayan, S. ;

Cummings, C. ;

Deininger, M. ;

Shah, N. ;

McCormick, F. ;

Willis, S. ;

Daridon, A. ;

Unger, M. ;

Radich, J. P. .

LEUKEMIA, 2009, 23 (02) :396-399

[6] Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype [J].

Schnittger, S ;

Schoch, C ;

Kern, W ;

Mecucci, C ;

Tschulik, C ;

Martelli, MF ;

Haferlach, T ;

Hiddemann, W ;

Falini, B .

BLOOD, 2005, 106 (12) :3733-3739

[7] Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia:: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease [J].

Schnittger, S ;

Schoch, C ;

Dugas, M ;

Kern, W ;

Staib, P ;

Wuchter, C ;

Löffler, H ;

Sauerland, CM ;

Serve, H ;

Büchner, T ;

Haferlach, T ;

Hiddemann, W .

BLOOD, 2002, 100 (01) :59-66

[8] Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML [J].

Schnittger, Susanne ;

Kern, Wolfgang ;

Tschulik, Claudia ;

Weiss, Tamara ;

Dicker, Frank ;

Falini, Brunangelo ;

Haferlach, Claudia ;

Haferlach, Torsten .

BLOOD, 2009, 114 (11) :2220-2231

[9] The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML [J].

Shayegi, Nona ;

Kramer, Michael ;

Bornhaeuser, Martin ;

Schaich, Markus ;

Schetelig, Johannes ;

Platzbecker, Uwe ;

Roellig, Christoph ;

Heiderich, Caroline ;

Landt, Olfert ;

Ehninger, Gerhard ;

Thiede, Christian .

BLOOD, 2013, 122 (01) :83-92

[10] Next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3-ITD or NPM1 mutations [J].

Thol, Felicitas ;

Koelking, Britta ;

Damm, Frederik ;

Reinhardt, Katarina ;

Klusmann, Jan-Henning ;

Reinhardt, Dirk ;

von Neuhoff, Nils ;

Brugman, Martijn H. ;

Schlegelberger, Brigitte ;

Suerbaum, Sebastian ;

Krauter, Juergen ;

Ganser, Arnold ;

Heuser, Michael .

GENES CHROMOSOMES & CANCER, 2012, 51 (07) :689-695

← 1 →